Literature DB >> 6145793

Facilitation at single release sites of a sympathetic neuroeffector junction in the mouse.

A G Blakeley, A Mathie, S A Petersen.   

Abstract

Electrophysiological techniques were used to observe the release of transmitter from one or a few release sites of the sympathetic neuroeffector junction of the mouse vas deferens. Release produces transient accelerations of the depolarizing phase of the excitatory junction potential, known as 'discrete events'. Discrete events associate into families at a constant latency and peak time, but vary in amplitude between a few preferred values. As facilitation develops there is a decrease in the frequency of small members of families and an increase in the frequency of large members, a change in apparent 'quantal content'. A similar change in amplitude distribution occurs when the [Ca]o is raised. The alpha-adrenoceptor antagonist yohimbine increases quantal content when facilitation has developed, but has no significant effect on unfacilitated discrete event amplitude unless the [Ca]o is below 2.0 mM. The alpha-adrenoceptor agonist clonidine reduces facilitated and unfacilitated quantal content under all conditions examined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145793      PMCID: PMC1199323          DOI: 10.1113/jphysiol.1984.sp015142

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  7 in total

1.  The packeted release of transmitter from the sympathetic nerves of the guinea-pig vas deferens: an electrophysiological study.

Authors:  A G Blakeley; T C Cunnane
Journal:  J Physiol       Date:  1979-11       Impact factor: 5.182

2.  The role of calcium in neuromuscular facilitation.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

3.  Secretion of transmitter from individual varicosities of guinea-pig and mouse vas deferens: all-or-none and extremely intermittent.

Authors:  T C Cunnane; L Stjärne
Journal:  Neuroscience       Date:  1982       Impact factor: 3.590

4.  Local regulation of transmitter release from rodent sympathetic nerve terminals?

Authors:  A G Blakeley; T C Cunnane; S A Petersen
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

5.  Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle.

Authors:  G D Hirst; T O Neild
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

6.  An electropharmacological analyses of the effects of some drugs on neuromuscular transmission in the vas deferens of the guinea-pig.

Authors:  A G Blakeley; T C Cunnane; S A Petersen
Journal:  J Auton Pharmacol       Date:  1981-12

7.  Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens.

Authors:  P Alberts; T Bartfai; L Stjärne
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

  7 in total
  4 in total

1.  Statistics of quantal secretion during long trains of sympathetic nerve impulses in mouse vas deferens.

Authors:  S Karunanithi; M C Phipps; J Robinson; M R Bennett
Journal:  J Physiol       Date:  1995-11-15       Impact factor: 5.182

2.  Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens.

Authors:  A G Blakeley; A Mathie; S A Petersen
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  A novel electrophysiological approach to monitor pulse by pulse the concentration of released noradrenaline at the presynaptic alpha 2-adrenoceptors of sympathetic nerves in rat tail artery.

Authors:  M Msghina; F Gonon; L Stjärne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

4.  Electrical and optical study of nerve impulse-evoked ATP-induced, P2X-receptor-mediated sympathetic neurotransmission at single smooth muscle cells in mouse isolated VAS deferens.

Authors:  J S Young; K L Brain; T C Cunnane
Journal:  Neuroscience       Date:  2007-07-16       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.